title: [Repermeability of portal vein after intra-arterial lipiodol chemotherapy in patients with hepatocellular carcinoma. Report of 3 cases].
authors.forename: S
authors.initials: S
authors.lastname: Derhy
authors.forename: L
authors.initials: L
authors.lastname: Bessis
authors.forename: R
authors.initials: R
authors.lastname: Atallah
authors.forename: Y
authors.initials: Y
authors.lastname: Ajavon
authors.forename: G
authors.initials: G
authors.lastname: Eisele
authors.forename: A
authors.initials: A
authors.lastname: Roche
mesh_terms: D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000188:drug therapy*; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007269:Injections, Intra-Arterial; D007459:Iodized Oil / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000150:complications*; D008113:Liver Neoplasms / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011169:Portal Vein; D013924:Thrombophlebitis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D007459:Iodized Oil; D004317:Doxorubicin
vernacular_title: Reperméabilisation portale après chimiothérapie lipiodolée intra-artérielle au cours d'un carcinome hépatocellulaire. A propos de 3 cas.